Casdin Capital and Corvex Management’s SPAC CM Life Sciences III files for a $400 million IPO

CM Life Sciences III, the third blank check company formed by Casdin Capital and Corvex Management targeting a life science business, filed on Thursday with the SEC to raise up to $400 million in an initial public offering.

The New York, NY-based company plans to raise $400 millRead More